Area of research
Psychiatry and Mental health · Cognitive Neuroscience
Research interest
Research focused on Bipolar disorder and Schizophrenia (object-oriented programming), with related work in Antipsychotic, Clozapine, Ceramide. Notable publications include 'Acid sphingomyelinase/ceramide system in schizophrenia: implications for therapeutic intervention as a potential novel target', 'Mechanistic/mammalian target of rapamycin and side effects of antipsychotics: insights into mechanisms and implications for therapy', and 'Clozapine induces metformin-resistant prediabetes/diabetes that is associated with poor clinical efficacy in patients with early treatment-resistant schizophrenia'.
Acid sphingomyelinase/ceramide system in schizophrenia: implications for therapeutic intervention as a potential novel target
Mechanistic/mammalian target of rapamycin and side effects of antipsychotics: insights into mechanisms and implications for therapy
Exploring neurometabolic alterations in bipolar disorder with suicidal ideation based on proton magnetic resonance spectroscopy and machine learning technology
Lithium produces bi-directionally regulation of mood disturbance, acts synergistically with anti-depressive/-manic agents, and did not deteriorate the cognitive impairment in murine model of bipolar disorder
Transcranial direct current stimulation of the occipital lobes with adjunct lithium attenuates the progression of cognitive impairment in patients with first episode schizophrenia
Associations of cognitive impairment in patients with schizophrenia with genetic features and with schizophrenia-related structural and functional brain changes
Electrical stimulus combined with venlafaxine and mirtazapine improves brain Ca2+ activity, pre-pulse inhibition, and immobility time in a model of major depressive disorder in schizophrenia
Proposed protocol for the investigation of the safety and efficacy of the COVID-19 vaccine for patients with psychosis, with pilot safety findings from a Chinese psychiatrist’s self-experiment
PubMed Central 2022cited by 2position: middle
In the era of whole-brain mapping for the exploration of mental disorders, we need to rethink our methods of rodent model establishment
Clozapine induces metformin-resistant prediabetes/diabetes that is associated with poor clinical efficacy in patients with early treatment-resistant schizophrenia
Safety and Efficacy of High-Dose Vitamin B6 as an Adjunctive Treatment for Antipsychotic-Induced Hyperprolactinemia in Male Patients With Treatment-Resistant Schizophrenia
Clozapine Induces Metformin-Resistant Prediabetes/Diabetes that Is Associated with Poor Clinical Efficacy in Patients with Early Treatment-Resistant Schizophrenia
Safety and efficacy of high-dose vitamin B6 for treating antipsychotic-induced hyperprolactinemia in male patients with treatment-resistant schizophrenia